FY2025 · ended Dec 31, 2025 · Revenue $15.23M, -52.6% YoY · Filed Mar 30, 2026
Allurion Technologies, Inc. (ALUR) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $15.2 million and a net loss of $28.8 million. As of Mar 31, 2026 it held $5.1 million in cash and investments and $896,000 in total debt.
Revenue (TTM)
$12.60M
-55.5% vs year-ago TTM
Net income (TTM)
$-33.35M
-211.8% vs year-ago TTM
Operating cash flow (TTM)
$-22.70M
+47.4% vs year-ago TTM
Free cash flow
$-42.91M
+34.6% vs prior year
EPS (TTM)
$-3.46
+5.1% vs year-ago TTM
Dividend per share
None
Shares outstanding
14.99M
+151.4% vs prior year
Net cash
$4.16M
as of Mar 31, 2026
Operating margin
-211.2%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ALUR (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Natick, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1964979
- Former names
- ALLURION TECHNOLOGIES HOLDINGS, INC. (until Aug 1, 2023)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
|---|---|---|---|
| Revenue | $15.2M | $32.1M | $53.5M |
| Operating income | -$30.2M | -$50.2M | -$79.1M |
| Net income | -$28.8M | -$7.2M | -$82.8M |
| Diluted EPS | -$3.81 | -$3.20 | -$59.38 |
| Operating cash flow | -$28.9M | -$42.3M | -$64.0M |
| Free cash flow | — | -$42.9M | -$65.6M |
| Total assets | $15.8M | $32.8M | $71.7M |
| Total liabilities | $93.0M | $110.8M | $143.0M |
| Stockholders' equity | -$77.2M | -$78.0M | -$71.3M |
| Cash and investments | $5.4M | $15.4M | $38.0M |
| Total debt | $969,000 | $37.9M | $41.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Aug 24, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale
|
Jul 24, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 23, 2026 | Jul 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 30, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jun 17, 2026 | Jun 12, 2026 |
All 318 Allurion Technologies, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.